138 related articles for article (PubMed ID: 14704863)
41. Haptoglobin phenotypes, which one is better and when?
Zvi B; Levy AP
Clin Lab; 2006; 52(1-2):29-35. PubMed ID: 16506361
[TBL] [Abstract][Full Text] [Related]
42. Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD).
Rydén L; Standl E; Bartnik M; Van den Berghe G; Betteridge J; de Boer MJ; Cosentino F; Jönsson B; Laakso M; Malmberg K; Priori S; Ostergren J; Tuomilehto J; Thrainsdottir I; Vanhorebeek I; Stramba-Badiale M; Lindgren P; Qiao Q; Priori SG; Blanc JJ; Budaj A; Camm J; Dean V; Deckers J; Dickstein K; Lekakis J; McGregor K; Metra M; Morais J; Osterspey A; Tamargo J; Zamorano JL; Deckers JW; Bertrand M; Charbonnel B; Erdmann E; Ferrannini E; Flyvbjerg A; Gohlke H; Juanatey JR; Graham I; Monteiro PF; Parhofer K; Pyörälä K; Raz I; Schernthaner G; Volpe M; Wood D; ;
Eur Heart J; 2007 Jan; 28(1):88-136. PubMed ID: 17220161
[No Abstract] [Full Text] [Related]
43. The genetics of vascular complications in diabetes mellitus.
Farbstein D; Levy AP
Cardiol Clin; 2010 Aug; 28(3):477-96. PubMed ID: 20621252
[TBL] [Abstract][Full Text] [Related]
44. [Genetics of cardio-vascular complications of diabetes].
Soubrier F
Ann Endocrinol (Paris); 1996; 57(3):155-9. PubMed ID: 8949409
[TBL] [Abstract][Full Text] [Related]
45. Pharmacogenomic application of the haptoglobin genotype in the prevention of diabetic cardiovascular disease.
Blum S; Milman U; Shapira C; Levy AP
Pharmacogenomics; 2008 Aug; 9(8):989-91. PubMed ID: 18681772
[No Abstract] [Full Text] [Related]
46. The effect of vitamin E supplementation on cardiovascular risk in diabetic individuals with different haptoglobin phenotypes.
Levy AP; Gerstein HC; Miller-Lotan R; Ratner R; McQueen M; Lonn E; Pogue J
Diabetes Care; 2004 Nov; 27(11):2767. PubMed ID: 15505023
[No Abstract] [Full Text] [Related]
47. [Genetic susceptibility to diabetic microangiopathy].
Gotoda T
Nihon Rinsho; 2005 Jun; 63 Suppl 6():85-90. PubMed ID: 15999690
[No Abstract] [Full Text] [Related]
48. Structure-function analysis of the antioxidant properties of haptoglobin.
Melamed-Frank M; Lache O; Enav BI; Szafranek T; Levy NS; Ricklis RM; Levy AP
Blood; 2001 Dec; 98(13):3693-8. PubMed ID: 11739174
[TBL] [Abstract][Full Text] [Related]
49. Factor V Leiden (F5 Q506) and vascular disease in Canadian Oji-Cree.
Hegele RA; Harris SB; Cao H; Hanley AJ; Zinman B
Diabetes Care; 1998 Jul; 21(7):1203. PubMed ID: 9653621
[No Abstract] [Full Text] [Related]
50. Haptoglobin genotype and diabetic microangiopathies in Japanese diabetic patients.
Koda Y; Soejima M; Yamagishi S; Amano S; Okamoto T; Inagaki Y; Yamada K; Kimura H
Diabetologia; 2002 Jul; 45(7):1039-40. PubMed ID: 12187922
[No Abstract] [Full Text] [Related]
51. The effect of vitamin E supplementation on cardiovascular risk in diabetic individuals with different haptoglobin phenotypes.
Blum S; Vardi M; Levy NS; Miller-Lotan R; Levy AP
Atherosclerosis; 2010 Jul; 211(1):25-7. PubMed ID: 20223458
[No Abstract] [Full Text] [Related]
52. Genetics of macrovascular complications in diabetes.
Fumeron F; Reis AF; Velho G
Curr Diab Rep; 2006 Apr; 6(2):162-8. PubMed ID: 16542628
[TBL] [Abstract][Full Text] [Related]
53. The Role of Haptoglobin Polymorphism in Cardiovascular Disease in the Setting of Diabetes.
Somer S; Levy AP
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33396615
[TBL] [Abstract][Full Text] [Related]
54. Haptoglobin genotype and the iron hypothesis of atherosclerosis.
Viener HL; Levy AP
Atherosclerosis; 2011 May; 216(1):17-8. PubMed ID: 21353224
[No Abstract] [Full Text] [Related]
55. Epidemiological and genetic approach to cardiovascular disease.
Tiret L
Pathol Biol (Paris); 1998 Nov; 46(9):715-6. PubMed ID: 9885828
[No Abstract] [Full Text] [Related]
56. Genetics, genomics, proteomics: what is a cardiologist to do?
Califf RM
Am Heart J; 2000 Oct; 140(4):S48-50. PubMed ID: 11011324
[No Abstract] [Full Text] [Related]
57. Genetic susceptibility to cardiovascular diseases.
Roses AD
Am Heart J; 2000 Oct; 140(4):S45-7. PubMed ID: 11011323
[No Abstract] [Full Text] [Related]
58. Genetic analysis for common complex disease.
Hauser ER; Pericak-Vance MA
Am Heart J; 2000 Oct; 140(4):S36-44. PubMed ID: 11011322
[No Abstract] [Full Text] [Related]
59. Socially sensitive research.
Weber LJ; Bissell MG
Clin Leadersh Manag Rev; 2002; 16(4):244-5. PubMed ID: 12168429
[No Abstract] [Full Text] [Related]
60. Update in cardiology: evidence published in 2010.
Redberg RF
Ann Intern Med; 2011 Apr; 154(8):549-53. PubMed ID: 21464339
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
